Vimian Group AB
Research Vimian Group AB (VIMIAN) on Bullrun: market cap SEK 18.77B, P/E 46.2. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerVIMIAN
- ExchangeST
- CountrySweden
- SectorHealthcare
- IndustryDiagnostics & Research
- CurrencySEK
- Market capSEK 18.77B
- P/E46.2
- Financial periodQ2 2026
- RevenueEUR 121.60M
- Net incomeEUR 8.40M
- Free cash flow-EUR 900.00K
- Gross margin68.4%
Valuation Snapshot
latest market cap is SEK 18.77B; P/E is 46.2.
Peer valuation comparison
Latest P/E is 46.17x versus a Healthcare sector median of 24.46x (88.8% above).
Latest P/E is 46.17x versus a Sweden median of 18.57x (148.6% above).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-28 | SEK 18.77B | 46.2 | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 SEK.
About Vimian Group AB
Vimian Group AB (publ) engages in the animal health business worldwide. It operates through four segments: Specialty Pharma, MedTech, Diagnostics, and Veterinary Services. The company offers proprietary diagnostics, prescription, and non-prescription treatments for preventive care and treatment of chronic conditions for companion animals under the Nextmune brand name;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Vimian Group AB's market cap?
Vimian Group AB's market capitalization is SEK 18.77B.
What is Vimian Group AB's P/E ratio?
Vimian Group AB's price-to-earnings (P/E) ratio is 46.2.
What does Vimian Group AB do?
Vimian Group AB (publ) engages in the animal health business worldwide. It operates through four segments: Specialty Pharma, MedTech, Diagnostics, and Veterinary Services. The company offers proprietary diagnostics, prescription, and non-prescription treatments for preventive care and treatment of chronic conditions for companion animals under the Nextmune brand name; and molecular and immunodiagnostic solutions that are used by laboratories for veterinary specific applications with a focus on livestock and companion animal health markets under the Indical Bioscience brand name.